The OPBC-07/microNAC Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Walter Paul Weber, Prof. Dr.
University Hospital, Basel, Switzerland
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
84 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sanatorio Modelo Quilmes
Quilmes, Argentina
- Chris O'Brien Lifehouse (cobl)
Sydney, Australia
- Ordensklinikum Linz Gmbh
Linz, Austria
- Medical University of Vienna Chirurgie
Vienna, Austria
- Hospital de Base Do Distrito Federal
Brasília, Brazil
- Sirio Libanes Hospital Brasilia
Brasília, Brazil
- Hospital Nossa Senhora Das Graças
Curitiba, Brazil
- Hospital Geral de Fortaleza
Fortaleza, Brazil
- Instituto Do Cancer Do Ceará
Fortaleza, Brazil
- Hospital de Câncer Araújo Jorge
Goiânia, Brazil
- Instituto de Mastologia E Oncologia
Goiânia, Brazil
- Instituto D'Or de Pesquisa E Ensino
São Paulo, Brazil
- Sirio Libanes Hospital
São Paulo, Brazil
- Sir Mortimer B. Davis Jewish General Hospital
Montreal, Canada
- Arturo Lopez Perez Foundation
Providencia, Chile
- Institute of Radiation Medicine
Vitacura, Chile
- Clinical Hospital Center Rijeka
Rijeka, Croatia
- Mansoura Oncology Center
Al Mansurah, Egypt
- University Hospital Augsburg
Augsburg, Germany
- University Hospital Düsseldorf
Düsseldorf, Germany
- Kem | Clinics Essen-Mitte
Essen, Germany
- University Hospital Heidelberg
Heidelberg, Germany
- University Hospital Lübeck
Lübeck, Germany
- University General Hospital of Heraklion
Heraklion, Greece
- Athens Medical Center
Marousi, Greece
- Sheba Medical Center
Ramat Gan, Israel
- Insituto Europeo Di Oncologia
Milan, Italy
- University Hospital Federico Ii
Naples, Italy
- Iov Padua
Padova, Italy
- Clinici Scientifici Maugeri Irccs
Pavia, Italy
- Fondazione Policlinico Universitario Agostino Gemelli Irccs
Roma, Italy
- Pauls Stradiņš Clinical University Hospital
Riga, Latvia
- National Cancer Institute
Vilnius, Lithuania
- the Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital
Amsterdam, Netherlands
- Oslo University Hospital
Oslo, Norway
- Dow University of Health Sciences
Karachi, Pakistan
- Hospital Nacional Guillermo Almenara Irigoyen
La Victoria, Peru
- Instituto Nacional de Enfermedades Neoplasicas
Surquillo, Peru
- University Hospital Zielona Gora
Zielona Góra, Poland
- Champalimaud Foundation
Lisbon, Portugal
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 May 2024
- Primary completion
- 30 Jun 2025
- Completion
- 30 Jun 2025
- Last update posted
- 24 Jan 2025
- Registered enrollment
- 2,000
- Registry id
- NCT06529302
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.